These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 1686352)

  • 61. Natural killer cell activity against cultured melanoma cells: a dye-reduction technique with studies on augmented activity by interferon subtypes.
    Losinno C; Wines BD; Johns TG; Mackay IR
    Nat Immun; 1992; 11(4):215-24. PubMed ID: 1384830
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Successful treatment of warm antibody (IgG/C3 positive) autoimmune hemolytic anemia in hairy-cell leukemia with 2-CdA in the elderly.
    Viens D; St-Hilaire E; Beauregard P; Dufresne J; Knecht H
    Leuk Lymphoma; 2008 Jul; 49(7):1424-6. PubMed ID: 18452105
    [No Abstract]   [Full Text] [Related]  

  • 63. The treatment of hairy cell leukemia: an update.
    Golomb HM; Ratain MJ; Mick R; Daly K
    Leukemia; 1992; 6 Suppl 2():24-7. PubMed ID: 1349662
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Effects of non-immune interferons and interleukin-2 on the activity of natural killer cells in patients with hairy cell leukemia].
    Schippa M; Fizzotti M; Cini L; Senatore M
    Medicina (Firenze); 1988; 8(2):163-6. PubMed ID: 3265755
    [No Abstract]   [Full Text] [Related]  

  • 65. Inhibition of K and NK lymphocyte cytotoxicity by an inhibitor of adenosine deaminase and deoxyadenosine.
    Grever MR; Siaw MF; Coleman MS; Whisler RL; Balcerzak SP
    J Immunol; 1983 Jan; 130(1):365-9. PubMed ID: 6600187
    [No Abstract]   [Full Text] [Related]  

  • 66. Effects of several species of human leukocyte interferon on cytotoxic activity of NK cells and monocytes.
    Ortaldo JR; Mantovani A; Hobbs D; Rubinstein M; Pestka S; Herberman RB
    Int J Cancer; 1983 Mar; 31(3):285-9. PubMed ID: 6826252
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Natural killer (NK) cell activity of women with gross cystic disease is inhibited in vitro by breast cyst fluid.
    Ardizzoja M; Masera RG; Tacconis P; Sartori ML; Arisio R; Massobrio M; Angeli A
    Anticancer Res; 1994; 14(2A):555-9. PubMed ID: 8017860
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Mechanism of augmentation of natural cytotoxicity by human beta-interferon.
    Marumo K; Ueno M; Hayakawa M; Jitsukawa S; Murai M; Tazaki H
    Keio J Med; 1984 Nov; 33(4):201-9. PubMed ID: 6530876
    [No Abstract]   [Full Text] [Related]  

  • 69. Relative roles of natural killer- and T cell-mediated anti-leukemia effects in chronic myelogenous leukemia patients treated with interferon-alpha.
    Pawelec G; Da Silva P; Max H; Kalbacher H; Schmidt H; Bruserud O; Zügel U; Baier W; Rehbein A; Pohla H
    Leuk Lymphoma; 1995 Aug; 18(5-6):471-8. PubMed ID: 8528055
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Synergism between alpha-interferon and interleukin-2-activated killer cells: in vitro studies.
    Di Raimondo F; LaPushin R; Hersh EM
    Acta Haematol; 1987; 78 Suppl 1():77-83. PubMed ID: 3124452
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Immunological activities of recombinant interferon-alpha 2 and its A fragment.
    Attallah AM; Fleisher TA; Hu R; Abdel-Gaffar H; Ibrahim S; Metwali A; Zoon K
    J Interferon Res; 1987 Apr; 7(2):223-9. PubMed ID: 3611842
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Variants in the cytotoxic activity of natural killers against interferon-modified target cells].
    Cheknëv SB; Narovlianskiĭ AN; Amchenkova AM; Sorokin AM
    Dokl Akad Nauk SSSR; 1990; 315(5):1270-4. PubMed ID: 2088695
    [No Abstract]   [Full Text] [Related]  

  • 73. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Oral antilymphocyte activity and induction of apoptosis by 2-chloro-2'-arabino-fluoro-2'-deoxyadenosine.
    Carson DA; Wasson DB; Esparza LM; Carrera CJ; Kipps TJ; Cottam HB
    Proc Natl Acad Sci U S A; 1992 Apr; 89(7):2970-4. PubMed ID: 1348362
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of low doses of an oxazaphosphorine on natural killer activity of human lymphocytes.
    Blomgren H
    Cancer Immunol Immunother; 1989; 29(2):151-3. PubMed ID: 2720708
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Comparative studies between in vitro and in vivo effects of human beta-interferon on natural killer activity and its relevance to immunochemotherapy.
    D'Atri S; Fuggetta MP; Giganti G; Tentori L; Roselli M; Nunziata C; Pastore S; Bonmassar E; De Vecchis L
    Cancer Immunol Immunother; 1988; 27(2):163-70. PubMed ID: 3416325
    [TBL] [Abstract][Full Text] [Related]  

  • 77. 2-Chlorodeoxyadenosine in the treatment of multiple myeloma.
    Dimopoulos MA; Kantarjian HM; Estey EH; Alexanian R
    Blood; 1992 Sep; 80(6):1626. PubMed ID: 1355673
    [No Abstract]   [Full Text] [Related]  

  • 78. Interferon-induced augmentation of natural killer cell activity by splenocytes from leukemia virus immunosuppressed mice.
    Specter S; Bendinelli M; Cox WI; Friedman H
    Adv Exp Med Biol; 1983; 162():497-501. PubMed ID: 6869094
    [No Abstract]   [Full Text] [Related]  

  • 79. Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells.
    Fink PC; Klaproth C; Peter HH
    Infection; 1984; 12(5):322-7. PubMed ID: 6392103
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [Studies on human natural killer (NK) cell activity against cell lines derived from malignant urinary tract tumors. Part 1. Effects of human interferon-beta on augmentation of NK cell activity and its mechanism].
    Hayakawa M; Schmitz-Dräger BJ; Ackermann R
    Nihon Hinyokika Gakkai Zasshi; 1984 Jan; 75(1):32-42. PubMed ID: 6737817
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.